Neil Black

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Effect of Eucaloric High- and Low-Sucrose Diets With Identical Macronutrient Profile on Insulin Resistance and Vascular Risk

Neil Black, Michelle Spence, R. McMahon et al. · Diabetes · 2006 · 90 citations · Full text

Nutrition, Healthy Subjects, Glycemic Profiles +17

Is There Value in Routine Screening for Cushing’s Syndrome in Patients with Diabetes?

Karen Mullan, Neil Black, Athinia Thiraviaraj et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 65 citations

A multicentre, <scp>UK</scp>, retrospective, observational study to assess the effectiveness of insulin glargine 300 units/ml in treating people with Type 1 diabetes mellitus in routine clinical practice (<scp>SPARTA</scp>)

Terence Pang, Stephen C. Bain, Neil Black et al. · Diabetic Medicine · 2018 · 24 citations · Full text

The peroxisome proliferator-activated receptor alpha agonist fenofibrate has no effect on insulin sensitivity compared to atorvastatin in type 2 diabetes mellitus; a randomised, double-blind controlled trial

Neil Black, C. N. Ennis, Ian Young et al. · Journal of Diabetes and its Complications · 2014 · 22 citations

Metabolic Syndrome, Insulin Sensitivity, Diabetes Management +13